Ildong Pharmaceutical Co., Ltd.
KSC: 249420.KS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Korea Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Yun Paul Woongsup
- Employees
- 1,033
- Headquarters
- Seoul, South Korea
- IPO year
- 2016
- Market cap
- ₩727.8B
- Website
- https://www.ildong.com
Loading 249420…
Loading profile data…Frequently asked questions about 249420
What does Ildong Pharmaceutical Co., Ltd. (249420.KS) do?
Ildong Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in South Korea. The company offers active lactic acid bacterial and anti-diarrheal agents, antibiotics, antifungal and antiviral products, anti-histamine drugs, antineoplastic agents, and NSAIDs and analgesics, as well as vitamins, minerals, and nutrients;...
Where does 249420.KS trade?
Ildong Pharmaceutical Co., Ltd. (249420.KS) trades on the Korea Exchange.
What sector is 249420.KS in?
Ildong Pharmaceutical Co., Ltd. (249420.KS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Ildong Pharmaceutical Co., Ltd.?
Yun Paul Woongsup is the chief executive officer of Ildong Pharmaceutical Co., Ltd. (249420.KS).
Where is Ildong Pharmaceutical Co., Ltd. headquartered?
Ildong Pharmaceutical Co., Ltd. is headquartered in South Korea.
Does 249420.KS pay a dividend?
Yes — Ildong Pharmaceutical Co., Ltd. (249420.KS) paid a trailing twelve-month dividend of KRW 200.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 249420.KS go public?
Ildong Pharmaceutical Co., Ltd. (249420.KS) completed its initial public offering in 2016.